Diagnostics

Plasma p-tau181 to identify Alzheimer’s disease-related co-pathology in DLB

Discriminative power of a multi-PET tracer approach in primary tauopathies

A single question dementia screening method

Voice-recognition based screening for MCI and dementia in older Chinese adults

Plasma tau217 occupancy as accurate as validated CSF tests

DROP-AD: detecting Alzheimer’s disease biomarkers in a single blood spot

A novel cognitive assessment based on augmented reality and machine learning

Digital biomarkers to revolutionize clinical trial conduction in Alzheimer’s disease

Blood-based biomarkers for AD diagnosis

Sex differences in Alzheimer’s disease: women’s journey, challenges, and implications

Detecting retinal Aβ: a promising path for non-invasive Alzheimer’s disease diagnosis

Use of AD blood-based biomarkers for trial enrolment

Expanding research into biomarkers for RPD differentiation

How feasible is an Alzheimer’s disease blood test in the UK?

Streamlining dementia diagnosis with digital biomarkers

Digital markers detect changes in neurocognitive performance in those with vs without hearing loss